Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell
-
B6032 CB-5083Target: p97Summary: p97 inhibitor
-
A3823 SJB2-043Target: USPSummary: USP1 inhibitor
-
A3920 Vinblastine sulfate2 CitationSummary: Anti-mitotic agent
-
A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor
-
A2606 Epoxomicin25 CitationSummary: Proteasome inhibitor
-
A2585 MG-13226 CitationTarget: ProteasomeSummary: Proteasome inhibitor, Cell permeable, reversible
-
A4011 ONX-0914 (PR-957)6 CitationTarget: ProteasomeSummary: Immunoproteasome inhibitor,potent and selective
-
A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S proteasome inhibitor
-
A2612 MG-1151 CitationTarget: ProteasomeSummary: Potent reversible proteasome inhibitor